The Global Non-Metal Orthopedic Biomaterial Market Is Expected To Grow At A CAGR Of 7.5% From 2022 To 2030.

Non Metal Orthopaedic Biomaterial Market Overview:

Non-metallic orthopedic biomaterials are materials used in the manufacture of medical implants in the skeletal system. These implants can be used to replace or repair bones, joints or other parts of the skeleton. Non-metallic orthopedic biomaterials are often made of plastic or ceramic materials, and are popular because they are less likely to cause side effects in the body than metal implants.

The growth of this market can be attributed to the increasing prevalence of musculoskeletal disorders, growing geriatric population and technological advances in biomaterials. The ceramic segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increased demand for ceramic implants due to their superior mechanical properties and biocompatibility compared to other implant materials. In terms of application, the joint replacement segment is expected to dominate the global non-metallic orthopedic biomaterials market during the forecast period. This growth may be due to the increased prevalence of joint diseases such as arthritis and osteoarthritis, which leads to bone damage and implant failure in these patients.

Non Metal Orthopaedic Biomaterial market size, estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Non Metal Orthopaedic Biomaterial market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and the Russian-Ukraine war.

Major Market Segments Covered in Non Metal Orthopaedic Biomaterial Industry Research:

Market Key Players:
Koninklijke DSM N.V., Wright Medical Group, Amedica Corporation, Globus Medical, Zimmer Biomet Holdings Inc., Exactech Inc., Johnson & Johnson, Acumed, Medtronic PLC, Stryker Corporation

By Type:

• Polymer
• Ceramic
• Composite

By Application:

• Joint Replacement
• Spine Implant
• Oestosynthesis
• Orthobilogics
• Other

By Region:

North America dominated the global market with over 38.0% in terms of revenue share in 2016. This region is expected to continue to dominate over the forecast period due to the increasing prevalence of osteoarthritis and other joint-related disorders coupled with growing preference for minimally invasive surgery. Additionally, high healthcare spending and favorable reimbursement policies are also expected to propel growth over the forecast period. Asia Pacific is expected to grow at a lucrative pace during the forecast period, owing to growing medical tourism industry, growing awareness among patients worldwide about advanced biomaterials used in orthopedic procedures, along with improvements in healthcare infrastructure.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Denmark
  • Finland
  • Iceland
  • Sweden
  • Norway
  • Belgium
  • The Netherlands
  • Luxembourg
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Benelux Union
• Rest of Europe
• Asia-Pacific
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Rest of Southeast Asia
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Significant Market Dynamics:

Growth Factors:

The global non-metallic orthopedic biomaterials market is expected to witness significant growth during the forecast period, owing to increasing frequency of hip and knee replacements due to aging population and active lifestyle.

Additionally, technological advancements in 3D printing are expected to further propel the market growth during the forecast period.

3D printing technology is increasingly being used in the manufacture of orthopedic implants as it helps reduce surgical time and cost.

Non Metal Orthopaedic Biomaterial Market report scope:

Key Takeaways from this Non Metal Orthopaedic Biomaterial Report

• Estimate Non Metal Orthopaedic Biomaterial market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, applications and by different industry verticals.
• Understand the supply chain in depth on the value growth at each step, in order to optimize value and bring effectiveness in your processes.
• Know the different dynamics affecting the market - challenges, key driving factors and opportunities.
• Get a quick viewpoint on the Non Metal Orthopaedic Biomaterial market entropy - M&A's, deals, partnerships, product launches of all key companies for the historical 5 years.
• Estimate the supply-demand gaps, import-export data and regulatory landscape for more than top 20 countries worldwide for the market.
• Get complete insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
• Study the sales and distribution channels over key geographies to improve top-line revenues.

Frequently Asked Questions-

What is the CAGR of Non Metal Orthopaedic Biomaterial market?

The Non Metal Orthopaedic Biomaterial Market is growing at a CAGR of 7.5% During Forecast Period.

 What are the key types of Non Metal Orthopaedic Biomaterial market?

Ceramic, Polyethylene, Composite

What are the key applications of Non Metal Orthopaedic Biomaterial market?

Joint Replacement, Spine Implant, Oestosynthesis, Orthobilogics, Other    

Who are the key players in Non Metal Orthopaedic Biomaterial market?

Koninklijke DSM N.V., Wright Medical Group, Amedica Corporation, Globus Medical, Zimmer Biomet Holdings Inc., Exactech Inc., Johnson & Johnson, Acumed, Medtronic PLC, Stryker Corporation